Leonardo DRS, Inc. (DRS) Financial Statements
Leonardo DRS, Inc. (DRS) reported trailing twelve-month revenue of $3.8B (up 10.5% year on year) and net income of $322.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $363.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DRSLeonardo DRS, Inc.Follow DRS — free
—
Price chart with a free account
- Market cap
- 9.2B
- P/E TTM
- 29.0
- Dividend yield
- 1.0%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 2.88 | 2.69 | 2.83 | 3.23 | 3.65 | 3.78 | |
| Gross profit | 0.55 | 0.58 | 0.65 | 0.74 | 0.87 | 0.94 | |
| Research & development | 0.05 | 0.06 | 0.08 | 0.09 | 0.13 | 0.14 | |
| Operating income | 0.24 | 0.56 | 0.23 | 0.29 | 0.35 | 0.40 | |
| Pre-tax income | 0.20 | 0.53 | 0.19 | 0.26 | 0.34 | 0.39 | |
| Income tax | 0.05 | 0.12 | 0.02 | 0.05 | 0.06 | 0.07 | |
| Net income | 0.15 | 0.41 | 0.17 | 0.21 | 0.28 | 0.32 | |
| Diluted EPS ($) | 0.73 | 1.88 | 0.64 | 0.80 | 1.03 | 1.19 | |
| Diluted shares (bn) | — | 0.215 | 0.264 | 0.268 | 0.269 | — |
USD billions · SEC XBRL
Leonardo DRS, Inc. — questions
- What is Leonardo DRS, Inc.'s revenue?
- $3.8B over the twelve months to 2026-06-30, up 10.5% year on year, from its 10-Q and 10-K filings.
- What is Leonardo DRS, Inc.'s net income?
- $322.0M over the twelve months to 2026-06-30.
- What is Leonardo DRS, Inc.'s free cash flow?
- $363.0M over the twelve months to 2026-06-30.
- What are Leonardo DRS, Inc.'s diluted earnings per share?
- $1.19 over the twelve months to 2026-06-30.
Every figure on this page comes from Leonardo DRS, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.